Evidence map›Paper›PMID 33659295›Full record

ArticleBio-protocol2020

Evaluation of the Efficiency of Genome Editing Tools by a Frameshift Fluorescence Protein Reporter.

Balaji T Moorthy, Akhilesh Kumar, Lauren X Lotenfoe, Fangliang Zhang

Open access · greenAbstract read
In one paragraph

Article in Bio-protocol, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Balaji T MoorthyDept. of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, FL 33136, USA.
Akhilesh KumarDept. of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, FL 33136, USA.
Lauren X LotenfoeDept. of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, FL 33136, USA.
Fangliang ZhangDept. of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, FL 33136, USA.
University of Miami · US

Funding

Regulation of cadherin-based cell adhesions by talin proteolysis and arginylationR01GM107333 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZHANG, FANGLIANG · 2013 to 2017
$1.5M
NIGMS NIH HHS R01 GM107333
6 · The paper itself

Abstract

In the last decade, genome editing has been the center of attention as a novel tool for mechanistic investigations and for potential clinical applications. Various genome editing tools like meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector-based nucleases (TALEN), and the clustered regularly interspaced short palindromic repeats (CRISPR)-associated genes (Cas), have been developed in recent years. For the optimal use as well as continued developments of these genome editing tools, the evaluation of their efficiencies and accuracies is vital. Here, we present a protocol for a reporter based on frameshift fluorescence protein which we recently developed to evaluate the efficiency and accuracy of genome editing tools. In this method, a ~20 bp target sequence containing frame-shifting is inserted after the start codon of a cerulean fluorescence protein (CFP) to inactivate its fluorescence, and only a new insertion/deletion event in the target sequence will reactivate the CFP fluorescence. To increase the traceability, an internal ribosome entry site and a red fluorescence protein, mCherryFP, are placed downstream of the reporter. The percentage of CFP-positive cells resulted from in/del mediated fluorescence restoration can be quantified by fluorescence measuring devices as the readout for genome editing frequency. As a demonstration, we present the usage for CRISPR-Cas9 technique here with flow cytometer as the readout for fluorescence changes.

Indexed as

CRIPSR-Cas9Genome editingIn-delInsertion-deletionNHEJReporter

Identifiers

PMID33659295
PMCPMC7842298
OpenAlexW3027082276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.